Cargando…
Preliminary characterization of N-trimethylchitosan as a nanocarrier for malarie vaccine
Autores principales: | Nnamani, Petra O, Nwodo, Ngozi J, Giacinto, Scoles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341295/ http://dx.doi.org/10.1186/1758-2946-4-S1-P47 |
Ejemplares similares
-
Eudragit(®) L100/N-Trimethylchitosan Chloride Microspheres for Oral Insulin Delivery
por: Marais, Etienne, et al.
Publicado: (2013) -
Characterization of anti-malarial resistance genes in pregnant and non-pregnant subjects of the northwest of Colombia
por: Arango, Eliana, et al.
Publicado: (2014) -
Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization
por: Mosafer, Jafar, et al.
Publicado: (2019) -
Galactosed and Reduction-Responsive Nanoparticles Assembled from Trimethylchitosan–Camptothecin Conjugates for Enhanced Hepatocellular Carcinoma Therapy
por: Fu, Chen, et al.
Publicado: (2022) -
A new anti-malarial drug against murine malaria
por: Zamani, Zahra, et al.
Publicado: (2011)